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On January 14, a bright light in the field of cancer
research was extinguished with the sudden death of
Dr. Judah Folkman. Folkman first introduced the con-
cept of tumour angiogenesis as a key factor in tumour
growth and a target for tumour therapy in 1970. De-
spite the great skepticism accorded his work, he per-
sisted in his studies. His efforts were eventually
vindicated and reproduced in numerous laboratories.
Indeed, an enormous number of labs continue to work
in the field that Judah Folkman initiated, and about a
dozen anti-angiogenic drugs are already on the market.
A native of Cleveland, Ohio, Judah Folkman
earned his Bachelor of Arts cum laude from Ohio
State University in 1953, and his MD magna cum laude
from Harvard Medical School in 1957. While an un-
dergraduate, he worked in Dr. Robert Zollinger’s sur-
gical laboratory and co-authored papers describing a
new method of hepatectomy for liver cancer. As a
student at Harvard Medical School, he worked in
Dr. Robert Gross’s laboratory, where he developed
the first atrioventricular implantable pacemaker, for
which he received the Boylston Medical Prize, the
Soma Weiss Award, and the Borden Undergraduate
Award in Medicine.
In 1957, Folkman began his surgical training at
the Massachusetts General Hospital, serving as its
chief resident in surgery in 1964–1965. That resi-
dency was interrupted between 1960 and 1962, when
he served as a lieutenant in the U.S. Navy at the Na-
tional Naval Medical Center in Bethesda. It was there
that he, along with colleague Dr. David Long, first
demonstrated the sustained release of drugs from im-
plantable silicone rubber polymers that led to the de-
velopment of the Norplant 5-year contraception
system and initiated the field of controlled-release
technology. It was also in Bethesda that Folkman car-
ried out experiments growing tumours in isolated per-
fused organs, which led to the idea that tumours are
angiogenesis-dependent, requiring new blood vessels
to survive.
In 1965, Folkman joined Harvard’s surgical ser-
vice, and in 1967, he was promoted to Professor of
Surgery at Harvard Medical School and to surgeon-
in-chief at the Children’s Hospital Medical Center,
becoming the Julia Dyckman Andrus Professor of
Pediatric Surgery in 1968.
Folkman’s discoveries related to the mechanism
of angiogenesis opened a field of investigation now
pursued worldwide. This work elaborated the hypoth-
esis that tumours can grow only if accompanied by
the development of feeder blood vessels—that is,
angiogenesis—and that malignancy may depend in
part on proteins that stimulate vascular growth. His
laboratory reported the first purified angiogenesis
molecule and the first angiogenesis inhibitor, pro-
posed the concept of angiogenic disease, and initi-
ated clinical trials based on that research. He
developed almost all of the methodology for the field,
including the first cloning and culture of capillary
endothelial cells, and sustained-release polymer tech-
nology, together with the in vivo bioassays for the
various phenomena involved. He elucidated the se-
quential steps of capillary networks, and he proposed
a linkage between cell shape and growth, currently
understood in terms of mechanochemical mediation
of gene expression by cytoskeletal elements.
Folkman’s exceptional achievements have been
recognized with numerous national and international
awards. On three separate occasions, he delivered the
commencement address at Harvard Medical School.
He was elected to the National Academy of Sciences
and was a member of the American Academy of Arts
and Sciences, the American Philosophical Society,
and the Institute of Medicine. Folkman also received
a Gairdner Foundation International Award and a
Christopher Columbus Discovery Award in Biomedi-
cal Research from the National Institutes of Health.
He was a recipient of the Wolf Prize in Medicine from
Israel. In 1993, he received the Lucian Award and a
DSc (Honoris Causa) from McGill University (among
his dozen or more honorary degrees).
Judah Folkman was a superb doctor, a brilliant
investigator, and a good friend. He will be much
missed.
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